MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update ...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across ...

To explore the role of brain and spinal cord MRI features in differentiating patients with suspected central nervous system (CNS) inflammatory diseases.Prospective data from 125 patients undergoing ...

Plano-based Texas Back Institute is joining Aclarion’s Clarity trial for augmented intelligence spine diagnostics. The Clarity trial is examining the Nociscan diagnostic tool’s clinical and economic ...

Texas Back Institute is a world leader in advancing spine technology, science, and education, as well as patient care ...